TP53 and small cell lung carcinoma: These mutations may contribute to the dysregulation of critical genes involved in cell proliferation and survival, leading to the development of SCLC, characterized by a high frequency of mutations in genes that regulate cell cycle and DNA damage response pathways, such as TP53, RB1, and PTEN.